Cargando…
Multiorgan Failure From Nivolumab and Ipilimumab: A Case Report and Literature Review
Immune checkpoint inhibitors (ICIs) as standard of care have revolutionized the treatment of patients with metastatic melanoma. The combination of nivolumab and ipilimumab improves treatment efficacy and prolongs survival compared to monotherapy alone. However, combination therapy is also associated...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419328/ https://www.ncbi.nlm.nih.gov/pubmed/37575835 http://dx.doi.org/10.7759/cureus.41781 |